BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) shares shot up 3.5% during trading on Monday . The company traded as high as $2.10 and last traded at $2.09. 11,352 shares changed hands during mid-day trading, an increase of 146% from the average session volume of 4,622 shares. The stock had previously closed at $2.02.
BioNexus Gene Lab Stock Up 2.9%
The company has a debt-to-equity ratio of 0.01, a quick ratio of 9.16 and a current ratio of 6.53. The firm has a fifty day simple moving average of $2.23 and a 200-day simple moving average of $3.15. The company has a market capitalization of $5.23 million, a PE ratio of -1.46 and a beta of 4.09.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last released its earnings results on Friday, May 15th. The company reported ($0.22) EPS for the quarter. BioNexus Gene Lab had a negative net margin of 54.70% and a negative return on equity of 37.43%. The business had revenue of $0.02 million for the quarter.
Institutional Investors Weigh In On BioNexus Gene Lab
BioNexus Gene Lab Company Profile
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
See Also
- Five stocks we like better than BioNexus Gene Lab
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
